Related Experiment Video

Updated: Jun 2, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Primary Congenital Glaucoma and the Involvement of CYP1B1

Kiranpreet Kaur1, Anil K Mandal, Subhabrata Chakrabarti

  • 1Kallam Anji Reddy Molecular Genetics Laboratory, Prof. Brien Holden Eye Research Centre, L.V. Prasad Eye Institute, Hyderabad, India.

Middle East African Journal of Ophthalmology
|May 17, 2011
PubMed

Insights

Primary congenital glaucoma (PCG) is a genetic eye disorder in children. Mutations in the CYP1B1 gene are linked to PCG, impacting trabecular meshwork development.

Area of Science:

  • Ophthalmology
  • Genetics
  • Developmental Biology

Background:

  • Primary congenital glaucoma (PCG) is an inherited condition affecting newborns.
  • It results from abnormal development of the eye's anterior chamber angle and trabecular meshwork.
  • PCG is more common in isolated populations and linked to consanguinity.

Purpose of the Study:

  • To review the pathogenesis of primary congenital glaucoma.
  • To explore the role of the CYP1B1 gene in PCG.
  • To discuss findings related to other genetic loci in developmental glaucoma.

Main Methods:

  • Review of existing literature on PCG genetics and pathogenesis.
  • Analysis of gene mapping studies identifying chromosomal loci (GLC3A, GLC3B, GLC3C, GLC3D).
  • Examination of mutation spectra and functional studies of the CYP1B1 gene.

Main Results:

  • Mutations in the CYP1B1 gene on the GLC3A locus are a primary cause of PCG.
  • CYP1B1 mutation patterns differ geographically but show population structure.
  • Structural and functional data suggest CYP1B1's role in glaucoma development.
  • A new locus, GLC3D, involving LTBP2, has been identified in developmental glaucoma.

Conclusions:

  • CYP1B1 mutations are central to PCG pathogenesis.
  • Understanding CYP1B1 variations is crucial for diagnosing and potentially treating PCG.
  • Further research is needed to clarify the role of LTBP2 in PCG.

Keywords:
CYP1B1GeneGlaucomaMutation

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...